928 related articles for article (PubMed ID: 15031681)
21. Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US.
Isozaki T; Numata K; Kiba T; Hara K; Morimoto M; Sakaguchi T; Sekihara H; Kubota T; Shimada H; Morizane T; Tanaka K
Radiology; 2003 Dec; 229(3):798-805. PubMed ID: 14563903
[TBL] [Abstract][Full Text] [Related]
22. Focal hepatic lesions: contrast-enhancement patterns at pulse-inversion harmonic US using a microbubble contrast agent.
Kim EA; Yoon KH; Lee YH; Kim HW; Juhng SK; Won JJ
Korean J Radiol; 2003; 4(4):224-33. PubMed ID: 14726639
[TBL] [Abstract][Full Text] [Related]
23. Characterization of focal hepatic lesions with contrast-enhanced C-cube gray scale ultrasonography.
Wang WP; Ding H; Qi Q; Mao F; Xu ZZ; Kudo M
World J Gastroenterol; 2003 Aug; 9(8):1667-74. PubMed ID: 12918098
[TBL] [Abstract][Full Text] [Related]
24. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound.
Dietrich CF; Schuessler G; Trojan J; Fellbaum C; Ignee A
Br J Radiol; 2005 Aug; 78(932):704-7. PubMed ID: 16046421
[TBL] [Abstract][Full Text] [Related]
25. Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging.
Hayashida M; Ito K; Fujita T; Shimizu A; Sasaki K; Tanabe M; Matsunaga N
Magn Reson Imaging; 2008 Jan; 26(1):65-71. PubMed ID: 17566685
[TBL] [Abstract][Full Text] [Related]
26. Characterization and detection of hepatocellular carcinoma (HCC): comparison of the ultrasound contrast agents SonoVue (BR 1) and Levovist (SH U 508A)--comparison of SonoVue and Levovist in HCC.
von Herbay A; Haeussinger D; Gregor M; Vogt C
Ultraschall Med; 2007 Apr; 28(2):168-75. PubMed ID: 17447216
[TBL] [Abstract][Full Text] [Related]
27. Contrast-enhanced sonography for the characterisation of hepatocellular carcinomas--correlation with histological differentiation.
Strobel D; Kleinecke C; Hänsler J; Frieser M; Händl T; Hahn EG; Bernatik T
Ultraschall Med; 2005 Aug; 26(4):270-6. PubMed ID: 16123920
[TBL] [Abstract][Full Text] [Related]
28. Correlation between SonoVue enhancement in CEUS, HCC differentiation and HCC diameter: analysis of 130 patients with hepatocellular carcinoma (HCC).
von Herbay A; Vogt C; Westendorff J; Häussinger D; Gregor M
Ultraschall Med; 2009 Dec; 30(6):544-50. PubMed ID: 19998208
[TBL] [Abstract][Full Text] [Related]
29. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?
Leoni S; Piscaglia F; Granito A; Borghi A; Galassi M; Marinelli S; Terzi E; Bolondi L
Ultraschall Med; 2013 Jun; 34(3):280-7. PubMed ID: 23616066
[TBL] [Abstract][Full Text] [Related]
30. Characterization of liver lesions by real-time contrast-enhanced ultrasonography.
Celli N; Gaiani S; Piscaglia F; Zironi G; Camaggi V; Leoni S; Righini R; Bolondi L
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):3-14. PubMed ID: 17206071
[TBL] [Abstract][Full Text] [Related]
31. [Value of contrast-enhanced ultrasound in the diagnosis of hepatocarcinoma in focal lesions detected in patients with liver disease].
Gómez Rodríguez RA; Artaza Varasa T; González de Frutos C; Sánchez Ruano JJ; Repiso Ortega A; Pérez-Grueso Macías MJ; Muñoz Rosas C; Carrobles Jiménez JM
Gastroenterol Hepatol; 2007; 30(7):381-6. PubMed ID: 17692194
[TBL] [Abstract][Full Text] [Related]
32. Hypoechoic focal liver lesions: characterization with contrast enhanced ultrasonography.
D'Onofrio M; Rozzanigo U; Masinielli BM; Caffarri S; Zogno A; Malagò R; Procacci C
J Clin Ultrasound; 2005 May; 33(4):164-72. PubMed ID: 15856516
[TBL] [Abstract][Full Text] [Related]
33. Liver haemangiomas undetermined at grey-scale ultrasound: contrast-enhancement patterns with SonoVue and pulse-inversion US.
Bartolotta TV; Midiri M; Quaia E; Bertolotto M; Galia M; Cademartiri F; Lagalla R
Eur Radiol; 2005 Apr; 15(4):685-93. PubMed ID: 15611873
[TBL] [Abstract][Full Text] [Related]
34. Solid focal liver lesions indeterminate by contrast-enhanced CT or MR imaging: the added diagnostic value of contrast-enhanced ultrasound.
Quaia E
Abdom Imaging; 2012 Aug; 37(4):580-90. PubMed ID: 21894508
[TBL] [Abstract][Full Text] [Related]
35. Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions.
Nicolau C; Vilana R; Catalá V; Bianchi L; Gilabert R; García A; Brú C
AJR Am J Roentgenol; 2006 Jan; 186(1):158-67. PubMed ID: 16357396
[TBL] [Abstract][Full Text] [Related]
36. Centrifugal (inside-out) enhancement of liver hemangiomas: a possible atypical appearance on contrast-enhanced US.
Bartolotta TV; Taibbi A; Galia M; Lo Re G; La Grutta L; Grassi R; Midiri M
Eur J Radiol; 2007 Dec; 64(3):447-55. PubMed ID: 17433596
[TBL] [Abstract][Full Text] [Related]
37. Differential Diagnosis of Arterial Phase Enhanced Hepatic Inflammatory Lesions and Hepatocellular Carcinomas with Contrast-enhanced Ultrasound.
Yang W; Yan K; Wang S; Dai Y; Wu W; Yin SS; Chen MH
Ultrasound Med Biol; 2016 Jan; 42(1):82-91. PubMed ID: 26456578
[TBL] [Abstract][Full Text] [Related]
38. An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography.
Wilson SR; Burns PN
AJR Am J Roentgenol; 2006 May; 186(5):1401-12. PubMed ID: 16632737
[TBL] [Abstract][Full Text] [Related]
39. Differentiation of focal liver lesions using three-dimensional ultrasonography: retrospective and prospective studies.
Luo W; Numata K; Morimoto M; Nozaki A; Ueda M; Kondo M; Morita S; Tanaka K
World J Gastroenterol; 2010 May; 16(17):2109-19. PubMed ID: 20440851
[TBL] [Abstract][Full Text] [Related]
40. Assessment of arterial-phase hyperenhancement and late-phase washout of hepatocellular carcinoma-a meta-analysis of contrast-enhanced ultrasound (CEUS) with SonoVue® and Sonazoid®.
Ren J; Lu Q; Fei X; Dong Y; D Onofrio M; Sidhu PS; Dietrich CF
Eur Radiol; 2024 Jun; 34(6):3795-3812. PubMed ID: 37989916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
